- The share
- Press releases
- Financial calendar
- Financial reports
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Contact us
- Thank you
XPS™ contract signed with leading hospital in Alabama
University of Alabama Birmingham is responsible for the only well-developed lung transplantation program in Alabama. The center has decided to purchase a XPS™ to establish an EVLP program and further develop the lung transplantation program.
XPS™ is the only CE-marked and FDA approved (Humanitarian Device Exemptions approval) integrated system on the market today which gives the user the flexibility to perform evaluation of lungs before transplantation through a standardized and simplified procedure. Use of XPS™ has shown good clinical results at 18 clinics in the US, many of which are national leaders in their field. Six XPS™ contracts have now been signed by European clinics, giving them access to the XPS™ system for lung transplantation, and the company notes continuing high interest for the XPS™ in the US and in Europe.
“We are delighted and proud that EVLP with XPS™ and STEEN Solution™ will be used for evaluating lungs for transplantation at the very well reputed University of Alabama Birmingham. This is the hospital performing lung transplantation in the state of Alabama, USA. The company sees a continued high interest from American and European clinics to set up XVIVOs XPS ™ system to facilitate lung evaluation with the aim of using more of the donated lungs”, says Magnus Nilsson, CEO of XVIVO Perfusion.
June 17, 2016
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +1 720 616 2101, email@example.com
Magnus Nilsson, CEO, +46 31 788 2150, firstname.lastname@example.org
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
The information was submitted for publication on June17, 2016 at 8:30 a.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.